UY28905A1 - Pestivirus atenuados con al menos una mutación en las secuencias codificadoras de glicoproteína erns y de npro, preparación y composiciones - Google Patents

Pestivirus atenuados con al menos una mutación en las secuencias codificadoras de glicoproteína erns y de npro, preparación y composiciones

Info

Publication number
UY28905A1
UY28905A1 UY28905A UY28905A UY28905A1 UY 28905 A1 UY28905 A1 UY 28905A1 UY 28905 A UY28905 A UY 28905A UY 28905 A UY28905 A UY 28905A UY 28905 A1 UY28905 A1 UY 28905A1
Authority
UY
Uruguay
Prior art keywords
mutation
npro
erns
compositions
vdvb
Prior art date
Application number
UY28905A
Other languages
English (en)
Spanish (es)
Inventor
Gregor Meyers
Andreas Ege
Christiane Meyer
Martina Von Freyburg
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34967522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY28905(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of UY28905A1 publication Critical patent/UY28905A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UY28905A 2004-05-19 2005-05-18 Pestivirus atenuados con al menos una mutación en las secuencias codificadoras de glicoproteína erns y de npro, preparación y composiciones UY28905A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025452A DE102004025452A1 (de) 2004-05-19 2004-05-19 Vakzine enthaltend BVDV

Publications (1)

Publication Number Publication Date
UY28905A1 true UY28905A1 (es) 2005-12-30

Family

ID=34967522

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28905A UY28905A1 (es) 2004-05-19 2005-05-18 Pestivirus atenuados con al menos una mutación en las secuencias codificadoras de glicoproteína erns y de npro, preparación y composiciones

Country Status (26)

Country Link
EP (1) EP1751276B9 (enExample)
JP (2) JP5006782B2 (enExample)
KR (1) KR100908798B1 (enExample)
CN (2) CN103352030B (enExample)
AR (2) AR049176A1 (enExample)
AT (1) ATE420949T1 (enExample)
AU (1) AU2005243488B2 (enExample)
BR (1) BRPI0510396B1 (enExample)
CA (1) CA2561719C (enExample)
CY (4) CY1109036T1 (enExample)
DE (2) DE102004025452A1 (enExample)
DK (1) DK1751276T5 (enExample)
ES (1) ES2321210T3 (enExample)
FR (3) FR15C0044I2 (enExample)
HU (2) HUS1500033I1 (enExample)
LU (3) LU92749I2 (enExample)
ME (1) ME01119B (enExample)
MX (1) MXPA06013298A (enExample)
NL (3) NL300743I1 (enExample)
NZ (1) NZ552088A (enExample)
PL (1) PL1751276T3 (enExample)
PT (1) PT1751276E (enExample)
RS (1) RS50753B9 (enExample)
SI (1) SI1751276T1 (enExample)
UY (1) UY28905A1 (enExample)
WO (1) WO2005111201A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US20090068223A1 (en) 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
CL2007002704A1 (es) 2006-09-22 2008-05-30 Intervet Int Bv Mutante de un pestivirus de una cepa citopatogenica con deleciones en la region codificante de la proteina npro del virus; vacuna que la comprende; y su uso para proteger al ganado vacuno contra la infeccion con un pestivirus tipo silvestre.
CL2008003202A1 (es) 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
SG10201506597RA (en) 2008-10-31 2015-10-29 Boehringer Ingelheim Vetmed Use Of Various Antigens Including Antigens From Mycoplasma Bovis In Multivalent Vaccine Composition
US8846054B2 (en) 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
BR112013006515B1 (pt) 2010-09-21 2020-04-28 Intervet Int Bv vacina de combinação, e, método para a fabricação de uma vacina de combinação
JP6589159B2 (ja) * 2014-04-01 2019-10-16 共立製薬株式会社 新規ネコモルビリウイルス株、不活化ワクチン製剤、並びにネコモルビリウイルス感染症予防方法
ES2757927T3 (es) * 2014-05-23 2020-04-30 Boehringer Ingelheim Vetmedica Gmbh Virus de la peste porcina clásica (VPPC) recombinante que comprende sustituciones en el epítopo TAV de la proteína E2
CN105779499B (zh) * 2016-03-23 2019-11-19 江苏科技大学 重组杆状病毒和其应用及构建该重组杆状病毒的载体
CN107823639B (zh) * 2017-11-10 2020-10-02 齐鲁动物保健品有限公司 牛病毒性腹泻病毒灭活疫苗及其制备方法
CN108707190B (zh) * 2018-04-18 2021-07-13 中国科学院武汉病毒研究所 猪瘟病毒ns5b蛋白保真度突变体及其应用
CN114853912B (zh) * 2022-05-24 2023-06-13 中国农业科学院兰州兽医研究所 一种牛病毒性腹泻病毒e2-e0融合蛋白、制备方法及应用
CN115960847B (zh) * 2023-01-11 2024-06-14 青岛大学 小分子依赖的内含肽自剪接系统在制备减毒活疫苗中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6168942B1 (en) * 1998-11-10 2001-01-02 Pfizer Inc. Attenuated forms of bovine viral diarrhea virus
EP1104676A1 (en) * 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
CA2363493C (en) * 2000-11-22 2006-06-06 Xuemei Cao Attenuated forms of bovine viral diarrhea virus
DE10143813A1 (de) * 2001-09-06 2003-04-10 Boehringer Ingelheim Vetmed Infektiöser Rindervirusdiarrhoe-Virusklon

Also Published As

Publication number Publication date
JP5562316B2 (ja) 2014-07-30
FR15C0043I1 (fr) 2015-07-24
AU2005243488B2 (en) 2011-07-07
WO2005111201A1 (en) 2005-11-24
CA2561719A1 (en) 2005-11-24
CN1989240A (zh) 2007-06-27
CA2561719C (en) 2015-01-27
FR15C0042I1 (fr) 2015-07-24
NL300743I2 (enExample) 2016-01-26
ME01119B (me) 2013-03-20
LU92749I2 (fr) 2015-11-02
AU2005243488A1 (en) 2005-11-24
EP1751276B9 (en) 2020-05-27
DK1751276T3 (da) 2009-05-18
CN103352030B (zh) 2018-08-10
RS50753B9 (sr) 2020-08-31
BRPI0510396A (pt) 2007-11-13
CY2015023I2 (el) 2024-02-16
EP1751276B1 (en) 2009-01-14
MXPA06013298A (es) 2007-05-07
PT1751276E (pt) 2009-02-24
AR104448A2 (es) 2017-07-19
DK1751276T5 (da) 2020-07-20
BRPI0510396B1 (pt) 2020-08-18
AR049176A1 (es) 2006-07-05
DE602005012381D1 (de) 2009-03-05
NL300744I1 (enExample) 2016-01-26
LU92747I2 (fr) 2015-11-02
KR100908798B1 (ko) 2009-07-22
LU92748I2 (fr) 2015-11-02
FR15C0043I2 (fr) 2016-05-27
HUS1500033I1 (hu) 2015-07-28
NL300744I2 (enExample) 2016-01-26
CY2015021I2 (el) 2023-11-15
CY2015022I1 (el) 2020-05-29
CY1109036T1 (el) 2014-07-02
NZ552088A (en) 2009-10-30
FR15C0042I2 (fr) 2018-11-16
CY2015021I1 (el) 2020-05-29
ATE420949T1 (de) 2009-01-15
NL300745I2 (enExample) 2016-01-26
SI1751276T1 (sl) 2009-06-30
JP5006782B2 (ja) 2012-08-22
CN103352030A (zh) 2013-10-16
CN1989240B (zh) 2013-07-31
CY2015022I2 (el) 2024-02-16
JP2012061001A (ja) 2012-03-29
ES2321210T3 (es) 2009-06-03
FR15C0044I2 (fr) 2016-05-27
CY2015023I1 (el) 2020-05-29
RS50753B (sr) 2010-08-31
DE102004025452A1 (de) 2006-01-19
KR20070012862A (ko) 2007-01-29
NL300743I1 (enExample) 2016-01-26
PL1751276T3 (pl) 2009-06-30
EP1751276A1 (en) 2007-02-14
ES2321210T9 (es) 2020-11-04
JP2007537740A (ja) 2007-12-27
NL300745I1 (enExample) 2016-01-26
FR15C0044I1 (fr) 2015-07-24
HUS1500031I1 (hu) 2019-11-28

Similar Documents

Publication Publication Date Title
AR049176A1 (es) Vacuna que comprende un pestivirus atenuado
ECSP066794A (es) Nuevos compuestos como inhibidores de serina proteasa ns3 del virus de la hepatitis c
IL202978A0 (en) West nile virus vaccine
NO20070551L (no) Vaksinesammensetninger og fremgangsmater for behandling av koronavirus infeksjon.
CL2010001569A1 (es) Pestivirus atenuado mediante la mutacion conjunta de las proteinas e erns y n pro.composicion inmunogenica y vacuna que lo comprende, metodo para atenuar pestivirus basado en la supresion de la dimerizacion de la proteina e rns y la ianactivacion de la proteina n pro.
UY33280A (es) Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf)
UY27465A1 (es) Métodos y composiciones para tratar flavivirus y pestivirus con 4' modificaciones nucleosides
AR026647A1 (es) Dispositivo para el suministro de farmacos que tienen propiedades antiprogestinicas
ECSP066466A (es) Mimeticuerpos humanos centrales de la region de bisagra, mimeticos de la eritropoyetina, composiciones, metodos y usos
CO5700788A2 (es) Composiciones y metodos para inmunoterapia especifica de wt1
ATE426412T1 (de) Adjuvante influenza-vakzine
CY1113738T1 (el) Εμβολια κατα της γριπης χαμηλης περιεκτικοτητας σε προσθετα
MY151062A (en) Pseudoinfectious flavivirus and uses thereof
CL2011002548A1 (es) Compuestos derivados de resolviina; composicion farmaceutica; uso de la composicion; kit farmaceutico; combinacion farmaceutica; uso de los compuestos en el tratamiento y/o prevencion de una condicion oftalmica.
NO20071924L (no) Vaksiner mot japansk ecefalittvirus og West Nile virus
AR082319A1 (es) Produccion de una n-acetilgalactosamina-6-sulfatasa humana activa altamente fosforilada y sus usos
NO20061911L (no) Immunogene sammensetninger
BRPI0909285A2 (pt) promotor, elementos de controle do promotor, e combinações e usos dos mesmos
ATE473745T1 (de) Verwendung von endoperoxiden zur behandlungvon infektionen durch flaviviridae, einschliesslich hepatitis c, viral rinder-diarrhöeund klassischer schweinefieber-virus
AR074483A1 (es) Composiciones, metodos y usos para inducir al crecimiento viral
EP1594509A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT OF IRRITABLE COLON SYNDROME AND NON ULCEREUS DYSPEPSIS
ECSP066805A (es) Compuestos silinano como inhibidores de cisteína proteasa
EA200301151A1 (ru) Вакцина против натуральной оспы
AR050085A1 (es) Procedimiento para la generacion de plantas transgenicas con resistencia aumentada a patogenos por modificacion del contenido y/o la actividad de factores despolimerizantes de actina.
UY30042A1 (es) Nuevos derivados de alquilfosfolípidos con citotoxicidad reducida y usos de los mismos.

Legal Events

Date Code Title Description
110 Patent granted

Effective date: 20190423

VENC Patent expired

Effective date: 20250518